BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Other Operating Assets
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Other Operating Assets of -$1.60 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2011-04-29
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for the quarter ending 2011-03-31 was -$1.60M, a 283.58% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for the quarter ending 2010-12-31 was $3.18M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for the quarter ending 2010-09-30 was -$498.00K, a 262.21% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for the quarter ending 2010-06-30 was $1.77M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for fiscal 2010 was $5.33M, a 314.15% increase from fiscal 2009.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for fiscal 2009 was $1.29M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating assets for fiscal 2008 was -$925.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2011-03-31 | -$1.60M 10-Q · filed 2011-04-29 | $1.58M derived: sum of 2 quarters · filed 2011-04-29 | $1.08M derived: sum of 3 quarters · filed 2011-04-29 | $2.86M derived: sum of 4 quarters · filed 2011-04-29 |
| 2010-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $2.68M derived: sum of 2 quarters · filed 2011-02-24 | $4.46M derived: sum of 3 quarters · filed 2011-02-24 | $5.33M 10-K · filed 2011-02-24 |
| 2010-09-30 | -$498.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $1.28M derived: sum of 2 quarters · filed 2010-10-29 | $2.15M 10-Q · filed 2010-10-29 | $1.45M derived: sum of 4 quarters · filed 2011-04-29 |
| 2010-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-04 | $2.65M 10-Q · filed 2010-08-04 | $1.95M derived: sum of 3 quarters · filed 2011-04-29 | $2.26M derived: sum of 4 quarters · filed 2011-04-29 |
| 2010-03-31 | $871.00K 10-Q · filed 2011-04-29 | $176.00K derived: sum of 2 quarters · filed 2011-04-29 | $483.00K derived: sum of 3 quarters · filed 2011-04-29 | |
| 2009-12-31 | -$695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | -$388.00K derived: sum of 2 quarters · filed 2011-02-24 | $1.29M 10-K · filed 2011-02-24 | |
| 2009-09-30 | $307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $1.98M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $1.67M 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | -$925.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |